The Cancer Research Institute (CRI) is learning to harness the power of the immune system to bring new and more effective approaches to cancer treatment, control, and prevention to cancer patients sooner. To accomplish this, CRI funds and coordinates an international network of laboratory and clinical research scientists working within the fields of immunology and tumor immunology. Through integration of basic and clinical research initiatives, CRI is accelerating the discovery, testing, and optimization of next-generation cancer immunotherapies such as cancer vaccines and antibodies.
The Cancer Research Institute identifies top scientific talent through the guidance of the CRI Scientific Advisory Council (SAC), an international roster of leaders in the field of immunology who support CRI's efforts to foster creative, scientifically rigorous research. The SAC counts among its members three Nobel Laureates, 31 members of the National Academy of Sciences, and 24 members of the Academy of Cancer Immunology.
Organization Mission Statements and About Us information are provided by GuideStar.
Now recruiting: Phase II study of checkpoint inhibitor durvalumab in patients with glioblastoma #btsm http://t.co/3c0KpzNpu9 12 Hours Ago
Enthusiasm, Questions for Immune Checkpoint Blockade in Lymphomas, via @OncLive http://t.co/LFu6bjRYbi 16 Hours Ago
Watch the story of one of the 1st patients treated w the recently FDA approved Yervoy + Opdivo combo for melanoma: http://t.co/1RmcaxS503 20 Hours Ago
Organizations Recommended For You
Duis non faucibus orci. Quisque in egestas ipsum. Morbi elementum nisl nisi, eget egestas ipsum varius ac. Nullam accumsan dolor sed malesuada mattis. Cras convallis metus dui, eu posuere tellus hendrerit in. Sed leo augue, rutrum in nunc sed, dapibus condimentum turpis.